Drug Product
Analytical & Bioanalytical Services
Company Overview
About
Novocol Pharma is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Formulation Development, Process Development, Scale-up
Therapeutic Areas
Oncology
Hematology
Quick Facts
HQ:Canada
Founded:2019
Employees:1,432
Capabilities & Services
Core Capabilities
- Oral Solid Dose
- Solid Dose Manufacturing
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Lyophilized (Freeze-Dried)
Sterile Injectable
Production Scales
Pilot Scale
Clinical
Commercial Scale
Markets Served
North America
Europe
Manufacturing Facilities
1 site worldwide
Novocol Pharmaceutical of Canada, Inc.
25 Wolseley Crt, Cambridge, Ontario N, 1R 6X3
Site Capabilities
1 capabilityMANUFACTURE
Regulatory Approvals
Drug Approval LEL3BR
FDA · #APR-2D178M3B · 2021-10-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-1X71BS40
Issued: 2020-04-28
Expires: 2025-07-01
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-HETB6D1S
Issued: 2020-11-21
Expires: 2025-11-08
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-JFGRR184
Issued: 2020-03-27
Expires: 2025-02-15
ISO 13485:2016
International Organization for Standardization
Cert #: CERT-I9ECNATV
Issued: 2020-03-17
Expires: 2025-06-02
Loading CDMO intelligence...
Key facts about Novocol Pharma
- Novocol Pharma is headquartered in Canada.
- Novocol Pharma was founded in 2019.
- Novocol Pharma has 1,432 employees.
- Novocol Pharma has one manufacturing site listed on CDMO Hub, in Cambridge, Canada.
- Novocol Pharma's capabilities include Oral Solid Dose, Solid Dose Manufacturing and Formulation Development.
Find CDMOs like Novocol Pharma
Directory pages this company appears in, each with the full list of matching manufacturers.